THROMBOEMBOLIC EVENTS POST CYTOREDUCTIVE SURGERY IN PATIENTS WITH OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER

被引：0
|
作者：
Atallah, D. [1 ]
Farraj, K. Abi [1 ]
Moubarak, M. [1 ]
El Kassis, N. [1 ]
Chahine, G. [2 ]
机构：
[1] St Joseph Univ, Hotel Dieu France Univ Hosp, Obstet & Gynecol, Beirut, Lebanon
[2] St Joseph Univ, Hotel Dieu France Univ Hosp, Oncol, Beirut, Lebanon
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.979
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP933
引用
收藏
页码：A500 / A500
页数：1
相关论文
共 50 条
  • [31] Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas
    Somasegar, Sahana
    Weiss, Arielle S.
    Norquist, Barbara M.
    Khasnavis, Nithisha
    Radke, Marc
    Manhardt, Enna
    Pennil, Christopher
    Pennington, Kathryn P.
    Eckert, Mark A.
    Chryplewicz, Agnieszka
    Lengyel, Ernst
    Swisher, Elizabeth M.
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 130 - 133
  • [32] Laparoscopic Assessment to Determine the Likelihood of Achieving Optimal Cytoreduction in Patients Undergoing Primary Debulking Surgery for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Andikyan, Vaagn
    Kim, Annie
    Gretz, Herbert F., III
    Zakashansky, Konstantin
    Prasad-Hayes, Monica
    Beddoe, Ann-Marie
    Dottino, Peter
    Mandeli, John
    Chuang, Linus
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 938 - 942
  • [33] Is Minimal Invasive Surgery for Primary and Secondary Debulking of Ovarian/Peritoneal/Fallopian Tube Cancer Going too Far?
    Gorostidi, Mikel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (07) : 1138 - 1139
  • [34] Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer
    Herzog, Thomas J.
    Powell, Matthew A.
    Rader, Janet S.
    Gibb, Randall K.
    Lippmann, Lynne
    Coleman, Robert L.
    Mutch, David G.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (03) : 467 - 473
  • [35] Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer - Reply
    Sabbatini, Paul
    Odunsi, Kunle
    CLINICAL CANCER RESEARCH, 2007, 13 (13) : 4026 - 4027
  • [36] Deliverability of Carboplatin and Weekly Paclitaxel as Adjuvant Therapy for Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients
    Sivakumaran, T.
    Zaheed, M.
    Freimund, A.
    Beale, P.
    Harrison, M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 72 - 72
  • [37] Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series
    Shih, K. K.
    Chi, D. S.
    Barakat, R. R.
    Leitao, M. M., Jr.
    GYNECOLOGIC ONCOLOGY, 2010, 117 (02) : 330 - 335
  • [38] Detection of NRG1 Fusion Events in Ovarian, Fallopian Tube, and Primary Peritoneal Carcinomas
    Evans, M.
    Tseng, J.
    Crymes, A.
    Reid, J.
    Oberley, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S123 - S123
  • [39] Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An updated series
    Shih, K. K.
    Chi, D. S.
    Barakat, R. R.
    Leitao, M. M.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S155 - S155
  • [40] Recommendations for diagnosis, treatment and follow-up of patients with ovarian cancer, fallopian tube cancer and primary peritoneal cancer
    Nina, Kovacevic
    Barbara, Segedin
    Sebastjan, Merlo
    Sonja, Bebar
    Ana, Blatnik
    Andrej, Cokan
    Branko, Cvjeticanin
    Nina, Fokter Dovnik
    Barbara, Gazic
    Biljana, Grcar Kuzmanov
    Brigita, Gregoric
    Matej, Horvat
    Vid, Jansa
    Jure, Knez
    Borut, Kobal
    Manja, Kobav
    Mateja, Krajc
    Maja, Krajec
    Mateja, Lasic
    Srdjan, Novakovic
    Maja, Pakiz
    Maja, Ravnik
    Spela, Smrkolj
    Ksenija, Strojnik
    Erik, Skof
    Iztok, Takac
    Gregor, Vivod
    Vesna, Zadnik
    Helena, Zobec Logar Barbara
    ONKOLOGIJA, 2022, 26 (02) : 92 - 119
12345